Rafarma Pharmaceuticals Stock Technical Analysis

RAFA Stock  USD 0.09  0.03  47.54%   
As of the 16th of December 2024, Rafarma Pharmaceuticals holds the Coefficient Of Variation of 850.13, semi deviation of 9.7, and Risk Adjusted Performance of 0.0948. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Rafarma Pharmaceuticals, as well as the relationship between them.

Rafarma Pharmaceuticals Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Rafarma, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Rafarma
  
Rafarma Pharmaceuticals' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Rafarma Pharmaceuticals technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Rafarma Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Rafarma Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Rafarma Pharmaceuticals Technical Analysis

Indicator
Time Period
Execute Indicator
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Rafarma Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Rafarma Pharmaceuticals Trend Analysis

Use this graph to draw trend lines for Rafarma Pharmaceuticals. You can use it to identify possible trend reversals for Rafarma Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Rafarma Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Rafarma Pharmaceuticals Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Rafarma Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of    , which means Rafarma Pharmaceuticals will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.04, which is the sum of squared deviations for the predicted Rafarma Pharmaceuticals price change compared to its average price change.

About Rafarma Pharmaceuticals Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Rafarma Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Rafarma Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Rafarma Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Rafarma Pharmaceuticals. By analyzing Rafarma Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Rafarma Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Rafarma Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.

Rafarma Pharmaceuticals December 16, 2024 Technical Indicators

Most technical analysis of Rafarma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Rafarma from various momentum indicators to cycle indicators. When you analyze Rafarma charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Rafarma Pharmaceuticals December 16, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Rafarma stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Complementary Tools for Rafarma Pink Sheet analysis

When running Rafarma Pharmaceuticals' price analysis, check to measure Rafarma Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rafarma Pharmaceuticals is operating at the current time. Most of Rafarma Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Rafarma Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rafarma Pharmaceuticals' price. Additionally, you may evaluate how the addition of Rafarma Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency